 The study examines ADRs reported over a threeyear period to a regional pharmacovigilance centre in Nepal  The possible reasons for under-reporting are discussed in this study.
 The study highlights the need for further research to identify causes for under-reporting
Background Abstract Background
Pharmacovigilance is the "science and activities relating to the detection, assessment, understanding and prevention of Pharmacovigilance is the "science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problems". Nepal joined the international pharmacovigilance programme as a full member in 2007. KIST Medical College, Lalitpur, Nepal joined the national programme as a regional centre from mid-July 2008. Currently, the pattern and scope of adverse drug reactions (ADRs) in Nepal remains unexplored. Aims To observe and analyse the pattern of ADRs at KIST Medical College, Lalitpur, Nepal. Method A retrospective analysis of all ADRs reported to the centre from mid July 2008 to July 2011 was performed. Data was analysed for ADR severity, causality, and preventability. Results A total of 113 ADR reports were obtained from various clinical departments. The maximum number of reactions was due to antimicrobials, followed by anti-hypertensives and NSAIDs. Conclusion Antimicrobials were the commonest group of drugs causing ADRs and the most commonly seen ADR was maculopapular rash followed by diarrhea and vomiting. adverse effects or any other drug related problems". 1 Pharmacovigilance plays an important role in rational use of medicines by providing information about adverse drug reactions (ADRs) in the general population. 1 In the year 2004, pharmacovigilance activities were initiated in Nepal which became a full member of the international pharmacovigilance programme in 2007. 2 The Department of Drug Administration (DDA), the national drug regulatory authority of Nepal acts as the national centre for ADR monitoring. KIST Medical College joined the programme as a regional centre from July 2008.
Pharmacovigilance in Nepal:
In Nepal, hospitals report ADRs to the regional pharmacovigilance centres from where reports are sent to the national pharmacovigilance centre. From there reports are sent to the Uppsala Monitoring Centre (UMC), Sweden, the international centre. At present, there are six regional pharmacovigilance centres located in teaching hospitals which report ADRs to the national centre via a web-based system called 'Vigiflow'.
In Nepal, there is no mandatory law necessitating drug manufacturers to submit safety data from the Nepalese population prior to approval of the medicines. Hence, it is very necessary to monitor side effects of the medicines Preventability assessment showed that only 13 (11.50%) of the reported ADRs were definitely preventable. Thirty (26.54%) ADRs were probably preventable and 70 (61.94%) were not preventable. Table 2 shows the different types of adverse drug reactions reported along with their frequency. 
Discussion
There was a higher prevalence of ADRs in females with a female: male ratio of 1: 0.74, which is comparable with other studies; one study showed a female: male ratio of 1: 0.87 10 while another study showed a ratio of 1.8:1.
11
Females have been identified as being at higher risk for developing ADRs. The underlying reasons may be various physiological reasons like menstruation, menarche, pregnancy, lactation and menopause and a stronger immune response in women. In a study from a South Indian hospital, the majority of patients experiencing ADRs were in the age group 21-40 years. 10 Another study in a tertiary care centre in South India showed the age group 20-39 years suffered from more ADRs.
12
The top 10 drugs responsible for causing ADRs reported to the national pharmacovigilance centre from centres all over the country were carbamazepine, phenytoin, amoxicillin, ciprofloxacin, diclofenac, isoniazid, ibuprofen, paracetamol, tramadol and cotrimoxazole. 13 The skin is the largest organ of the body and most ADRs are seen in the skin. 14 Maculopapular rashes were the most commonly reported type of ADR. This result is in concordance with the studies by Sushma et al. 10 and Puavilai and colleagues. 15 In our study, azithromycin was the most common drug causing ADRs followed by ibuprofen and amlodipine. In a study done by Fiszensin-Albala and coworkers from France, the main drug group responsible for ADRs was antibiotics. 16 However, another study done by
Noel and co-workers showed anti-epileptics as the major causative drugs for causing the ADRs. 17 The current system of reporting ADRs remains in its infancy. Future plans for the development of this system include: strengthening the reporting system by training the new faculties and medical officers in each department about the pharmacovigilance programe in our hospital; following up all clinical departments weekly for improving the quality of reporting; providing feedback to the clinicians about the progress of their reported reactions to facilitate an improvement in the problem of under-reporting. Medication errors and error reporting are still controversial issues and will have to be discussed before an error reporting programme can be initiated.
Limitations
Our study did not evaluate the association of ethnic group, caste and religion, and polypharmacy with ADRs. Also, some of the reports for ayurvedic and complementary medicines could not be assessed due to the lack of information regarding its composition, dose and frequency. Lack of awareness and information about medication errors and also non-availability of medication error reporting systems which is an important part of pharmacovigilance is a major limitation.
Conclusion
Antimicrobials were the commonest group of drugs causing ADRs and the most commonly observed ADR was maculopapular rash followed by vomiting and diarrhoea. Efforts are underway to encourage clinicians, nurses and other allied healthcare workers to report all ADRs even suspected ones, with the aim of improving medicine use.
